Search results
Results From The WOW.Com Content Network
Acute onset of breathing problems caused by fluid accumulation in lung extravascular spaces induced by immersion, usually in cold water, often with intense physical exertion. Symptoms reported developed during physical activity and usually include dyspnoea/shortness of breath and a cough, often haemoptysis, occasionally chest tightness, chest ...
Bird fancier's lung (BFL), also known as bird breeder's lung, is a type of hypersensitivity pneumonitis.It can cause shortness of breath, fever, dry cough, chest pain, anorexia and weight loss, fatigue, and progressive pulmonary fibrosis (the most serious complication).
It is expected that low doses of diphenhydramine taken occasionally will cause no adverse effects in breastfed infants. Large doses and long-term use may affect the baby or reduce breast milk supply, especially when combined with sympathomimetic drugs, such as pseudoephedrine, or before the establishment of lactation. A single bedtime dose ...
Respiratory arrest is a serious medical condition caused by apnea or respiratory dysfunction severe enough that it will not sustain the body (such as agonal breathing). Prolonged apnea refers to a patient who has stopped breathing for a long period of time. If the heart muscle contraction is intact, the condition is known as respiratory arrest.
Medium to long term exposure to high partial pressures (>c1.3 bar) of inert gas (usually N 2 or He) in the breathing gas. Decompression sickness ("the bends"): Injury due to gas bubbles expanding in the tissues and causing damage, or gas bubbles in the arterial circulation causing emboli and cutting off blood supply to tissues downstream of the ...
Diphenhydramine is a first-generation antihistamine and an anticholinergic drug. Anticholinergic drugs block the action of acetylcholine, a neurotransmitter in the central nervous system. [13] Studies propose that long-term use of anticholinergic drugs is associated with an increased risk for dementia among older people.
Post-exposure prophylaxis, also known as post-exposure prevention (PEP), is any preventive medical treatment started after exposure to a pathogen in order to prevent the infection from occurring. It should be contrasted with pre-exposure prophylaxis , which is used before the patient has been exposed to the infective agent.
NIV can be used acutely and long-term. In some people who have presented with acute respiratory failure, there is an ongoing need for long-term use of NIV at home. [2] Non-invasive ventilation has been suggested in the treatment for coronavirus disease 2019 (COVID-19) where shortages of invasive ventilation equipment and facilities may arise. [4]